Farha Mithila


Farha Mithila
BS, Biochemistry
University of Massachusetts - Boston
Boston, MA
PREP Scholar
Athar Chishti, PhD, Adviser




Sickle Cell Disease (SCD) is a genetic hematologic disorder characterized by sickle-shaped red blood cells (RBC). Sickle cell disease is a debilitating condition affecting nearly 100,000 people in the USA and millions of people in the world, particularly the population of sub-Saharan Africa. Our previous studies indicate that calpains, a family of calcium-dependent cysteine proteases, play an important role in regulating RBC shape and membrane properties. I am investigating the role of calpains in SCD using genetically modified mouse models. These studies may ultimately lead to the development of calpain inhibitors as potential therapeutics for sickle cell disease.

Back to the Chishti Profile Page

Apply to the Sackler School


The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development

Useful Links